Delivery Order SPE2DB20D2104-SPE2DB24FQ91L
- Not listed
- This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,688.04, is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 and runs through November 2026. This IDC serves as the primary...
- This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,081.35, is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
- This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,372.34, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under a broader Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- This federal contract award is for the delivery of Vyvanse 30mg capsules, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,071.61 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This contract is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, which enables the company to supply a comprehensive...
- This federal contract award is for the delivery of Vyvanse 50 mg capsules to the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The award, valued at $1,402.14, is a delivery order placed under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for a ceiling value of $1,564.56. The contract has an ultimate completion date of July 9, 2024 and is structured as a Firm Fixed Price Delivery Order. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award is for the delivery of Vyvanse 40mg capsules to the Defense Logistics Agency (DLA), a defense agency. The $1,024.00 contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA, valued up to $999,999,999.00 through December 2025. This single-award IDC serves as the...
- This federal contract award is for the delivery of Vyvanse capsules (40mg) to the Defense Logistics Agency (DLA), a defense agency. The $34,466.34 firm-fixed-price delivery order contract has a period of performance through May 28, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
- This federal contract award is for the delivery of Vyvanse 40 mg capsules to the Defense Logistics Agency (DLA), a major supplier of medical products and services to the U.S. Department of Defense. The contract was awarded to the Corporate Office division of Amerisourcebergen Drug Corp, a large pharmaceutical distribution company, and has a ceiling value of $2,952.43. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
- This federal contract award is for the delivery of Vyvanse 40mg capsules in 100-count packages, awarded to AmerisourceBergen Drug Corp by the Defense Logistics Agency (DLA). The $1,293 firm-fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has no set-aside designation, indicating open competition....
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FQ91LDelivery Order
This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $2,231.10, is a delivery order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen has also been awarded a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 10/26/23 |